Low-dose cyclophosphamide depletes circulating naïve and activated regulatory T cells in malignant pleural mesothelioma patients synergistically treated with dendritic cell-based immunotherapy.

Noordam, Lisanne; Kaijen, Margaretha E H; Bezemer, Koen; Cornelissen, Robin; Maat, Lex A P W M; Hoogsteden, Henk C; Aerts, Joachim G J V; Hendriks, Rudi W; Hegmans, Joost P J J; Vroman, Heleen

Noordam, Lisanne; Kaijen, Margaretha E H; Bezemer, Koen; Cornelissen, Robin; Maat, Lex A P W M; Hoogsteden, Henk C; Aerts, Joachim G J V; Hendriks, Rudi W; Hegmans, Joost P J J; Vroman, Heleen.

Afiliación

Noordam L; Department of Pulmonary Medicine, Erasmus MC, Rotterdam, The Netherlands.
Kaijen MEH; Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Bezemer K; Department of Pulmonary Medicine, Erasmus MC, Rotterdam, The Netherlands.
Cornelissen R; Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Maat LAPWM; Department of Pulmonary Medicine, Erasmus MC, Rotterdam, The Netherlands.
Hoogsteden HC; Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Aerts JGJV; Department of Pulmonary Medicine, Erasmus MC, Rotterdam, The Netherlands.
Hendriks RW; Department of Cardio-Thoracic Surgery, Erasmus MC, Rotterdam, The Netherlands.
Hegmans JPJJ; Department of Pulmonary Medicine, Erasmus MC, Rotterdam, The Netherlands.
Vroman H; Department of Pulmonary Medicine, Erasmus MC, Rotterdam, The Netherlands.